Mark Clarke, NPP32626

NPI: 1790850584
Total Payments
$29,684
2024 Payments
$7,367
Companies
59
Transactions
1,217
Medicare Patients
1,397
Medicare Billing
$104,733

Payment Breakdown by Category

Food & Beverage$29,684 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $29,684 1,217 100.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $2,349 68 $0 (2024)
Amgen Inc. $2,221 81 $0 (2024)
Janssen Pharmaceuticals, Inc $1,887 56 $0 (2024)
GlaxoSmithKline, LLC. $1,883 55 $0 (2024)
Vanda Pharmaceuticals Inc. $1,642 59 $0 (2024)
ABBVIE INC. $1,552 94 $0 (2024)
SANOFI-AVENTIS U.S. LLC $1,497 49 $0 (2023)
Abbott Laboratories $1,420 42 $0 (2024)
Lundbeck LLC $1,373 58 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $1,197 115 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $7,367 293 AstraZeneca Pharmaceuticals LP ($901.04)
2023 $8,090 294 Abbott Laboratories ($1,080)
2022 $6,551 292 Amgen Inc. ($540.77)
2021 $7,676 338 Janssen Pharmaceuticals, Inc ($998.38)

All Payment Transactions

1,217 individual payment records from CMS Open Payments — Page 1 of 49

Date Company Product Nature Form Amount Type
12/31/2024 Tolmar, Inc. JATENZO (Drug) Food and Beverage Cash or cash equivalent $24.30 General
Category: HORMONE REPLACEMENT
12/26/2024 PFIZER INC. ZAVZPRET (Drug) Food and Beverage In-kind items and services $12.08 General
Category: PAIN
12/23/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $28.46 General
Category: Psychology/Psychiatric
12/23/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $7.09 General
Category: Gastroenterology
12/18/2024 IDORSIA PHARMACEUTICALS US INC QUVIVIQ (Drug) Food and Beverage In-kind items and services $15.16 General
Category: Insomnia
12/18/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.93 General
Category: Gastroenterology
12/16/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $26.62 General
Category: Respiratory
12/13/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $19.29 General
Category: GASTROENTEROLOGY
12/12/2024 Inspire Medical Systems, Inc. INSPIRE (Device) Food and Beverage In-kind items and services $29.75 General
Category: NEUROLOGY
12/12/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $15.55 General
Category: TESTOSTERONE REPLACEMENT THERAPY
12/11/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $17.36 General
Category: NEUROSCIENCE
12/10/2024 Tolmar, Inc. JATENZO (Drug) Food and Beverage Cash or cash equivalent $13.52 General
Category: HORMONE REPLACEMENT
12/09/2024 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $29.30 General
Category: NEUROLOGY
12/04/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $24.05 General
Category: Psychology/Psychiatric
12/03/2024 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $33.61 General
Category: NEUROLOGY
12/03/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $4.76 General
Category: Inflammation
11/27/2024 Verity Pharmaceuticals Inc. Tlando (Drug) Food and Beverage Cash or cash equivalent $19.71 General
Category: Testosterone Replacement Therapy (TRT)
11/26/2024 Esperion Therapeutics, Inc. NEXLETOL (Drug) Food and Beverage In-kind items and services $16.45 General
Category: ANTILIPEMIC AGENTS
11/25/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $20.68 General
Category: Gastroenterology
11/25/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $14.47 General
Category: TESTOSTERONE REPLACEMENT THERAPY
11/22/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $20.81 General
Category: Oncology
11/14/2024 ABIOMED Impella (Device) Food and Beverage Cash or cash equivalent $21.27 General
Category: Cardiology/Vascular Diseases
11/14/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $17.78 General
Category: Respiratory
11/14/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $12.59 General
Category: TESTOSTERONE REPLACEMENT THERAPY
11/12/2024 Tolmar, Inc. JATENZO (Drug) Food and Beverage Cash or cash equivalent $16.60 General
Category: HORMONE REPLACEMENT

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 416 677 $75,515 $35,555
2022 7 353 567 $54,265 $27,294
2021 7 329 484 $45,095 $23,264
2020 7 299 450 $41,780 $18,620
Total Patients
1,397
Total Services
2,178
Medicare Billing
$104,733
Procedure Codes
29

All Medicare Procedures & Services

29 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 93 271 $29,435 $13,430 45.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 64 81 $10,935 $6,295 57.6%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 47 47 $9,165 $5,245 57.2%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2023 32 61 $8,235 $5,118 62.1%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 35 64 $8,000 $3,233 40.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 20 20 $4,000 $1,377 34.4%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 74 75 $4,875 $660.00 13.5%
81002 Urinalysis, manual test Office 2023 51 58 $870.00 $197.78 22.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 90 217 $20,615 $11,239 54.5%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 52 134 $13,360 $7,158 53.6%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 30 30 $5,850 $3,431 58.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 28 28 $5,600 $2,379 42.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 25 26 $3,510 $2,307 65.7%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 66 67 $4,355 $556.98 12.8%
81002 Urinalysis, manual test Office 2022 62 65 $975.00 $222.77 22.8%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 78 179 $17,005 $9,147 53.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 62 62 $12,090 $7,270 60.1%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2021 31 83 $7,885 $4,549 57.7%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 11 11 $2,200 $1,176 53.5%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2021 64 64 $4,160 $527.50 12.7%
82274 Stool analysis for blood, by fecal hemoglobin determination by immunoassay Office 2021 24 24 $840.00 $382.08 45.5%
81002 Urinalysis, manual test Office 2021 59 61 $915.00 $212.28 23.2%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 72 188 $17,860 $7,908 44.3%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 52 52 $10,140 $5,347 52.7%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2020 44 75 $7,125 $3,621 50.8%

About Mark Clarke, NPP32626

Mark Clarke, NPP32626 is a Family healthcare provider based in Smithfield, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790850584.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mark Clarke, NPP32626 has received a total of $29,684 in payments from pharmaceutical and medical device companies, with $7,367 received in 2024. These payments were reported across 1,217 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($29,684).

As a Medicare-enrolled provider, Clarke has provided services to 1,397 Medicare beneficiaries, totaling 2,178 services with total Medicare billing of $104,733. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location Smithfield, RI
  • Active Since 11/21/2006
  • Last Updated 05/26/2015
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1790850584

Products in Payments

  • XARELTO (Drug) $1,918
  • JARDIANCE (Drug) $1,505
  • NURTEC ODT (Drug) $1,263
  • HETLIOZ (Drug) $1,258
  • VRAYLAR (Drug) $1,239
  • TRINTELLIX (Drug) $1,197
  • FARXIGA (Drug) $1,168
  • FREESTYLE LIBRE 3 (Device) $1,133
  • VYEPTI (Biological) $1,087
  • Otezla (Drug) $1,075
  • TRELEGY ELLIPTA (Drug) $941.91
  • XIFAXAN (Drug) $729.72
  • BREZTRI (Drug) $717.87
  • TOUJEO (Biological) $667.28
  • Aimovig (Biological) $662.46
  • SOLIQUA 100/33 (Biological) $564.54
  • REXULTI (Drug) $496.53
  • Ozempic (Drug) $483.37
  • AREXVY (Drug) $481.85
  • Repatha (Biological) $410.32

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Smithfield